Incyte Corporation
Biotechnology & Medical Research
Company Summary
The biopharmaceutical business Incyte Corporation focuses on the research, development, and commercialization of patented therapies in the United States and globally. The business was founded in 1991 and is based in Wilmington, Delaware.
Website : http://www.incyte.com/
ESG Rating Overview
Sustainalytics
Overall ESG Rating :
23.8
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
LSEG
Overall ESG Rating :
46
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
MSCI
Overall ESG Rating :
BBB
Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader
Incyte is average among 43 companies in the biotechnology industry.
Temperature Rise :
1.6℃
CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned
